Very well could see that happen through the CTAP FDA guidelines. No question the next test which will be on Human Cell lines and then proceed to acute patients. Whatever happens it is full speed ahead with the US Gov't ensuring everything is in place for Widespread production and distribution. BP partner as well will be in play.
Only a matter of a short time before Trump gets briefed on Brilacidin.
There definitely will be quick follow-up to this with next steps. I expect Leo to keep this in front of everyone for a while...
Another point not really being discussed. The graphic shows B's potential as a prophylactic. B was introduced to the cell cultures BEFORE the virus and the viral load was compared later. The higher dose of B reduced viral load by about 50% if I'm reading it correctly. I wonder what would happen if B was introduced AFTER infection....